Laman UtamaONC • NASDAQ
add
BeOne Medicines AG
Tutup sebelumnya
$321.36
Julat hari
$321.18 - $330.43
Julat tahun
$172.67 - $330.43
Permodalan pasaran
38.73B USD
Bilangan Purata
425.80K
Nisbah P/E
-
Hasil dividen
-
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.32B | 41.56% |
Perbelanjaan pengendalian | 537.91J | 21.23% |
Pendapatan bersih | 94.32J | 178.34% |
Margin untung bersih | 7.17 | 155.32% |
Pendapatan bagi setiap syer | 0.84 | 173.04% |
EBITDA | 117.75J | 241.18% |
Kadar cukai berkesan | 5.25% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 2.76B | 6.30% |
Jumlah aset | 6.30B | 10.26% |
Jumlah liabiliti | 2.53B | 7.76% |
Jumlah ekuiti | 3.77B | — |
Syer tertunggak | 110.03J | — |
Harga kepada buku | 9.36 | — |
Pulangan pada aset | 3.62% | — |
Pulangan pada modal | 4.73% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Jun 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 94.32J | 178.34% |
Tunai daripada operasi | 263.60J | 375.76% |
Tunai daripada pelaburan | -66.60J | 40.01% |
Tunai daripada pembiayaan | 35.02J | 52.17% |
Perubahan bersih dalam tunai | 255.50J | 234.82% |
Aliran tunai bebas | 180.43J | 247.61% |
Perihal
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market.
BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025. Wikipedia
Diasaskan
28 Okt 2010
Tapak web
Pekerja
11,000
